
ICANS, Corticosteroid Use Identified As Risk Factors for NRM-Associated Infections After Axi-Cel Infusion in R/R NHL
Among patients with relapsed/refractory non-Hodgkin lymphoma (NHL), a notable percentage of non-relapse mortality (NRM) events were attributed to infections that delayed immune recovery following treatment with axicabtagene ciloleucel (axi-cel; …